Clinical Trial Update: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

Phase 2 trial of GSK2202083A vaccine in healthy infants completed; multiple conditions tested including tetanus, hepatitis B, Hib, polio, acellular pertussis, d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Neisseria Meningitidis Disease
• Poliomyelitis
• Tetanus

Drugs mentioned

• GSK2202083A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tetanus, Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2014-08-15